Associations between glycaemic deterioration and aortic stiffness and central blood pressure: the ADDITION-PRO Study

Nanna B Johansen1, Signe S Rasmussen, Niels Wiinberg

  • 1aResearch Centre for Prevention and Health, Centre for Health, Capital Region of Denmark, Glostrup bSteno Diabetes Center Copenhagen, Gentofte cDanish Diabetes Academy, Odense dDepartment of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød eDepartment of Clinical Physiology, Frederiksberg Hospital, Frederiksberg fDepartment of Medical Research, Holstebro Hospital and University of Aarhus, Holstebro gDepartment of Public Health, Section of General Practice, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.

Insights

Diabetes risk impacts aortic stiffness. Higher HbA1c at screening correlated with increased aortic stiffness (aPWV) and lower central diastolic blood pressure (DBP). Glycemic changes over time did not independently affect these measures.

Area of Science:

  • Cardiovascular disease research
  • Metabolic disorders and diabetes
  • Public health screening programs

Background:

  • Diabetes risk assessment is crucial for early intervention.
  • Central hemodynamics, including aortic stiffness and central blood pressure, are key indicators of cardiovascular health.
  • Understanding the relationship between glycemic control and hemodynamic parameters is vital for managing diabetes complications.

Purpose of the Study:

  • To investigate central hemodynamic profiles across different diabetes risk strata.
  • To analyze the association of glycated hemoglobin A1c (HbA1c) levels and changes with central hemodynamics.
  • To evaluate the impact of diabetes risk screening on cardiovascular health markers.

Main Methods:

  • A Danish population-based screening program identified seven diabetes risk groups.
  • Follow-up included 2048 individuals assessed for aortic stiffness (aPWV) and central blood pressure (BP) after 7.8 years.
  • Statistical analyses adjusted for confounders to examine HbA1c and its changes' impact on hemodynamics.

Main Results:

  • Individuals with high diabetes risk scores and impaired glucose tolerance exhibited higher aortic stiffness (aPWV), central systolic BP (SBP), diastolic BP (DBP), and pulse pressure.
  • A 1% point increase in screening HbA1c was linked to a 0.23 m/s increase in aPWV and a 1.35 mmHg decrease in central DBP.
  • Glycemic deterioration over the follow-up period showed no independent association with central hemodynamics.

Conclusions:

  • Dysglycemia, particularly at screening, is associated with increased future aortic stiffness.
  • While initial HbA1c levels influence central hemodynamics, glycemic changes over time do not independently predict aortic stiffness or central BP.
  • These findings highlight the importance of baseline glycemic status in assessing cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
650
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
686
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
537
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K